期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

RECK基因在恶性肿瘤浸润和转移中作用的研究进展 被引量：3

下载PDF
导出
摘要 由于恶性肿瘤对周围组织的浸润和其它器官的转移,现有的治疗手段（手术、化疗、放疗）难以奏效,治疗困难,病死率高。Ahmedin等[1]在2010年一项基于国立癌症研究所、疾病预防控制中心、北美癌症登记协会和国家卫生统计中心数据的一篇报道中指出,
作者 张洁 颜虹
机构地区 西安交通大学医学院第二附属医院 西安交通大学医学院公共卫生系
出处 《陕西医学杂志》 CAS 2011年第6期732-734,共3页 Shaanxi Medical Journal
关键词 浸润和转移 恶性肿瘤 RECK基因 疾病预防控制中心 癌症研究所 周围组织 卫生统计 癌症登记
分类号 R730 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1Ahmedin J,Rebecca S,Jiaquan Xu,et al.Cancer Statistics[J].Cancer J Clin,2010,60:277-0300.
  • 2Norihiro T,Mitsuhiro T,Yasuhiro H,et al.Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorte survival after resection in patients with adenocarcinoma of the lung[J].Lung Cancer,2007,58:376-383.
  • 3Makoto N,Junseo O,Rei T,et al.RECK:A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling[J].Cancer Metastasis Res,2003,22(2 3):167-175.
  • 4Takahashi C,Sheng Z,Horan TP,et al.Regulation of matrix metalloproteinase 9 and inhibition tumor invasion by the membraneanehored glycoprotein RECK[J].Proc Natl Acad Sci,1998,95(11):13221-13226.
  • 5Michiko E,Shunya K,Rei T,et al.The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors[J].Oncogene,2005,24:5850-5857.
  • 6Anitha J,George T.The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis[J].Pathol Oncol Res,2001,7(1):14-23.
  • 7Oh J,Takahashi R,Kondo S,et al.The membrane-Anchored MMP Inhibitor RECK Is a key regulator of extracellular matrix integrity and angiogenesis[J].Cell,2001,107(6):789-800.
  • 8Akira O,Tomoko M,Kazuhiro M,et al.RECK Forms Cowbell-shaped Dimers and Inhibits Matrix Metalloproteinase-catalyzed Cleavage of Fibronectin[J].BIO CHEM,2009,284(6):3461-3469.
  • 9Welm B,Mort J,Werb Z.Developmental biology:vasculogenesis is a wreck without RECK[J].Curr Biol,2002,12(6):209-211.
  • 10罗湘玉,郭家龙,左顺庆,张军.非小细胞肺癌中RECK基因的表达及其与MMP-9的关系[J].现代肿瘤医学,2009,17(7):1246-1249. 被引量：3

二级参考文献12

  • 1Takemoto N ,Tada M, Hida Y, et al. Low expression of reversion - inducing cysteine - rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarei- noma of the lung[ J]. Lung Cancer,2007,58 ( 3 ) :376 - 383.
  • 2Furumoto K, Arii S, Moil A, et al. RECK gene expression in hepatocellular carcinoma: correlation with invasion - related clinicopathological factors and its clinical significance. Reverse - inducing - cysteine - rich protein with Kazal motifs [ J ]. Hepatology, 2001,33 (1) :189 -195.
  • 3Asano T, Tada M, Cheng S, et al. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma[ J]. J Surg Res,2008,146( 1 ) :32 -42.
  • 4Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis [ J]. Cancer Metastasis Rev ,2006,25 ( 1 ) :9 - 34.
  • 5St - Pierre Y, Couillard J, Van Themsche C. Regulation of MMP - 9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases [ J ]. Expert Opin Ther Targets,2004,8 (5) :473 - 489.
  • 6Leinonen T, Pirinen R, Bohm J, et al. Expression of matrix metalloproteinases 7 and 9 in non - small cell lung cancer. Relation to clinicopathological factors, beta--catenin and prognosis [ J ]. Lung Cancer,2006,51 (3) :313 -321.
  • 7Oh J, Takahashi R, Kondo S, et al. The membrane - anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis [ J ]. Cell,2001,107 (6) :789 - 800.
  • 8Rydlova M, Holubec L Jr, Ludvikova M Jr, et al. Biological activity and clinical implications of the matrix metalloproteinases[ J ]. Anticancer Res,2008,28 (2) : 1389 - 1397.
  • 9Meng N,Li Y,Zhang H,et al. RECK,a novel matrix metalloproteinase regulator[ J ]. Histol Histopathol,2008,23 (8) : 1003 - 1010.
  • 10Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase - 9 and inhibition of tumor invasion by the membrane -anchored glycoprotein RECK [ J ]. Proc Nat Acad Sci USA, 1998,95(22) :13221 - 13226.

共引文献2

同被引文献37

  • 1Clark JC,Thomas DM,Choong PF, et aI.RECK-a newlydiscovered inhibitor of metastasis with prognostic significance in multiple forms of cancer[J].Cancer Metastasis Rev,2007,26(3-4):675-683.
  • 2Sledge GW.Implications of the new biology for the rapy in breast cancer[J].Semin Onco1,1996,23(1 Supp12):76-81.
  • 3Basset P, Okada A,Chenard MP.Matalloproteinase as stromaleffectors of human carcinoma progression: therapeutic implications[J].Matrix Bio,1997,15(8-9): 535- 540.
  • 4Ones JL,Glyrm P, Walker RA.Expression of MMP-2 and MMP-9.Their inhibit ors,and the activator MTI-MMP in primary breast carcinomas [J].Pathol, 1999,189(2): 161-168.
  • 5Nakopoulou L,Tsirmpa I,Alexandrou P, et al.MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival[J].Breast Cancer ResTreat, 2003,77(2): 145-155.
  • 6B0rriruicwanit K,Lafleur MA,Mercurif A,et al.The type 1 collagen induction of MTI- MMP- mediated MMP- 2 activation is repreased by alpha Vbeta3 integrin in human breast cancer eells[J].Matrix Biology,2007,26(4)291-305.
  • 7Nawrocki B,Polette M,Marchand V, et al.Expression of matrix matalIoproteinase and their inhibitors in human bronchopulmonary carcinomas- Quantificative and morphological analysis[J].Int J Cancer,1997,72: 556-564.
  • 8Mori M,Mimori K, Shlraishi T, et al.Analysis of MT1-MMP and MMP-2 expression in human gastric cancers[J].Int J Cancer, 1997,74.316-321.
  • 9Ellenrieder V, Alber B,Lacher U,et al.Role of MT-MMPs and MMP-2 in pancreatic cancer progression[J].Int J Cancer, 2000,85:14-20.
  • 10Nakamura H, Ueno H, Yamashita K,et al.Erdaanced production and activation of progelatinase A mediated by membrane-typel matrix metalloproteinase in human papillary thyroid careinomas[J].Cancer Res,1999,59: 463- 467.

引证文献3

二级引证文献6

陕西医学杂志
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部